North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Growth by 2028
North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Diagnosis (Breath Testing, Small Intestine Aspirate and Fluid Culture Test, Blood Test, and Others) and Type (Hydrogen-predominant SIBO, Methane-predominant SIBO, and Recurrent SIBO)
- Report Date : Sep 2021
- Report Code : TIPRE00025060
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 76
The North America small intestinal bacterial overgrowth (SIBO) diagnostics market is expected to grow from US$ 53,452.06 thousand in 2021 to US$ 73,794.03 thousand by 2028; it is estimated to grow at a CAGR of 4.7% from 2021 to 2028.
The US, Canada, and Mexico are economies in North America. Growing prevalence of IBS and SIBO is expected to surge the market growth. Irritable bowel syndrome (IBS) is the commonly diagnosed gastrointestinal disorder with abdominal pain and altered bowel habits resulting with associated symptoms such as bloating, malabsorption, and systemic symptoms. The incidences of IBS are increasing at a significant rate across the region. According to a research article, ‘Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study’ published by Elsevier Inc. in 2021, the US have a prevalence rate of 5.3%, respectively. The increasing prevalence of IBS across the region is due to the changing lifestyle and dietary habits. Small intestinal bacterial overgrowth (SIBO) is widely associated with the IBS. Likewise, SIBO shows similar symptoms to IBS. Technological developments have now allowed the diagnosis of SIBO while diagnosing IBS. Therefore, the prevalence of SIBO is widely understood and reported across the region. For instance, according to an article, ’Small Intestinal Bacterial Overgrowth: A Case-Based Review’ published in the Journal of Patient-Centered Research and Reviews (JPCRR) in November 2015, 30–85% of adult patients with IBS are likely to develop SIBO across the region. Similarly, according to the recent data published in 2020 by the American College of Gastroenterology, ~78% of IBS patients are living with SBIO; hence, it is a predominantly evaluated condition. It is, therefore, estimated that the prevalence of IBS and SIBO will grow significantly in the near future, leading to the increasing diagnosis and eventual North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics market growth.
In case of COVID-19, North America is highly affected specially the US. Industrial sectors in the countries such as the US and Canada has experienced disruption in various industries, including healthcare. However, the need for diagnosis and treatment for the COVID positive patients has carried on business cycles in the medical sector. In addition, the rising demand for personal protective equipment has tried to stabilize the business cycle for the healthcare industry. According to an article issued by Harvard Medical School, infectious viral particles can live in the air for three hours. As a result, it can cause patient scheduling obstructions and put others at risk for contracting the virus. For healthcare providers demanding to test for GI-related problems offered by patients, a substitute for in-office breath testing must be granted due to the potential spread of COVID-19 through aerosolization. Unfortunately, the possible aerosolization spread of COVID-19 makes breath testing in-office comparatively unsafe and has been in a bit of a dilemma in the clinic during this pandemic. The small intestinal bacterial overgrowth diagnostics market also witnessed major decline due to lowered number of diagnostic procedures. Substantial focus on management of COVID had direct impact on diagnostics of abdominal conditions such as irritable bowel syndrome, SIBO, and lactose intolerance. In addition, patients showed reluctance for breath and blood tests due to fear of COVID infection. These factors consequently led to adverse impact on North America small intestinal bacterial overgrowth market during the pandemic period. However, the market is expected to witness considerable growth post-pandemic. Certain factors such as rise in prevalence of SIBO and IBS are estimated to show positive impact on market growth.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America small intestinal bacterial overgrowth (SIBO) diagnostics market. The North America small intestinal bacterial overgrowth (SIBO) diagnostics market is expected to grow at a good CAGR during the forecast period. 
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Segmentation
North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – By Diagnosis
- Breath Testing
- 14C Xylose Breath Test
- Hydrogen Breath Tests
- 14C Glycocholic Acid Breath Test
- Malabsorption Tests
- Small Intestine Aspirate and Fluid Culture Test
- Blood Test
- Others
North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – By Type
- Hydrogen-predominant SIBO
- Methane-predominant SIBO
- Recurrent SIBO
North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Country
- US
- Canada
- Mexico
North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market -Companies Mentioned
- Aerodiagnostics, LLC.
- Commonwealth Diagnostics International
- DirectLabs, LLC.
- Genova Diagnostics
- Health Associates Medical Group
- Metabolic Solutions, Inc.
- Pivotal Diagnostics
- SIBO Diagnostics
- SIBOTest
- Vibrant Wellness
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – By Diagnosis
1.3.2 North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – By Type
1.3.3 North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Expert Opinion
5. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Growing Prevalence of IBS and SIBO
5.1.2 Increasing Advantages of Breath Test
5.2 Key Market Restraints
5.2.1 Limitations of Diagnosis
5.3 Key Market Opportunities
5.3.1 Escalation in the Usage of Capsule Technology
5.4 Future Trends
5.4.1 Rise of NGS Technologies to Diagnose SIBO
5.5 Impact Analysis
6. Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – North America Analysis
6.1 North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Revenue Forecast and Analysis
7. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Analysis– by Diagnosis
7.1 Overview
7.2 North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis 2020 & 2028 (%)
7.3 Breath Testing
7.3.1 Overview
7.3.2 Breath Testing: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
7.3.3C Xylose Breath Test
7.3.3.1 Overview
7.3.3.2C Xylose Breath Test: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
7.3.4 Hydrogen and Methane Breath Tests
7.3.4.1 Overview
7.3.4.2 Hydrogen and Methane Breath Tests: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
7.3.5C Glycocholic Acid Breath
7.3.5.1 Overview
7.3.5.2C Glycocholic Acid Breath: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
7.3.6 Malabsorption Tests
7.3.6.1 Overview
7.3.6.2 Malabsorption Tests: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
7.4 Small Intestine Aspirate and Fluid Culture Test
7.4.1 Overview
7.4.2 Small Intestine Aspirate and Fluid Culture Test: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
7.5 Blood Test
7.5.1 Overview
7.5.2 Blood Test: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
7.6 Others
7.6.1 Overview
7.6.2 Others: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
8. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Analysis– by Type
8.1 Overview
8.2 North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type 2020 & 2028 (%)
8.3 Hydrogen-predominant SIBO
8.3.1 Overview
8.3.2 Hydrogen-predominant SIBO: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
8.4 Methane-predominant SIBO
8.4.1 Overview
8.4.2 Methane-predominant SIBO: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
8.5 Recurrent SIBO
8.5.1 Overview
8.5.2 Recurrent SIBO: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
9. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Country Analysis
9.1 North America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market
9.1.1 Overview
9.1.2 North America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Country, 2020 & 2028 (%)
9.1.3 US: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.1.3.1 US: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.1.3.2 US: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)
9.1.3.2.1 US: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)
9.1.3.3 US: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)
9.1.4 Canada: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.1.4.1 Canada: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.1.4.2 Canada: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)
9.1.4.2.1 Canada: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)
9.1.4.3 Canada: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)
9.1.5 Mexico: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.1.5.1 Mexico: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
9.1.5.2 Mexico: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis, 2019–2028 (USD Thousand)
9.1.5.2.1 Mexico: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing, 2019–2028 (USD Thousand)
9.1.5.3 Mexico: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type, 2019–2028 (USD Thousand)
10. Impact of COVID-19 Pandemic on North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
11. Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 Genova Diagnostics
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 SIBO Diagnostics
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Commonwealth Diagnostics International
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Aerodiagnostics, LLC.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 SIBOTest
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Metabolic Solutions, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Pivotal Diagnostics
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 DirectLabs, LLC.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Vibrant Wellness
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Health Associates Medical Group
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
Table 2. US: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)
Table 3. US: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)
Table 4. US: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 5. Canada: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)
Table 6. Canada: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)
Table 7. Canada: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 8. Mexico: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Thousand)
Table 9. Mexico: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Breath Testing– Revenue and Forecast to 2028 (USD Thousand)
Table 10. Mexico: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Thousand)
Table 11. Organic Developments Done by Companies
Table 12. Inorganic Developments Done by Companies
Table 13. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Segmentation
Figure 2. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – By Country
Figure 3. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Overview
Figure 4. Breath Test Segment Held Largest Share of Market by Diagnosis
Figure 5. The US to Show Significant Growth During Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. Expert Opinion
Figure 8. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Impact Analysis of Drivers and Restraints
Figure 9. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue Forecast and Analysis
Figure 10. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Diagnosis 2020 & 2028 (%)
Figure 11. North America Breath Testing: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 12. North America 14C Xylose Breath Test: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 13. North America Hydrogen and Methane Breath Tests: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 14. North America 14C Glycocholic Acid Breath: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 15. North America Malabsorption Tests: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 16. North America Small Intestine Aspirate and Fluid Culture Test: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 17. North America Blood Test: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 18. North America Others: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 19. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Type 2020 & 2028 (%)
Figure 20. North America Hydrogen-predominant SIBO: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 21. North America Methane-predominant SIBO: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 22. North America Recurrent SIBO: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 23. North America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Key Country – Revenue (2020) (USD Thousand)
Figure 24. North America: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market, by Country, 2020 & 2028 (%)
Figure 25. US: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
Figure 26. Canada: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
Figure 27. Mexico: Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (USD Thousand)
Figure 28. Impact of COVID-19 Pandemic in North American Country Markets
- Aerodiagnostics, LLC.
- Commonwealth Diagnostics International
- DirectLabs, LLC.
- Genova Diagnostics
- Health Associates Medical Group
- Metabolic Solutions, Inc.
- Pivotal Diagnostics
- SIBO Diagnostics
- SIBOTest
- Vibrant Wellness
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Sep 2021
Wheelchair and Mobility Aids Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Wheelchairs (Manual, Powered, Power Assisted, and Accessories), Mobility Scooters, Walking Aids, and Others), Application (Neurologically Impaired, Handicap Patients, and Other Applications), End User (Homecare, Hospitals and Clinics, Rehabilitation Centers, and Others), and Distribution Channel (Online and Offline)
Sep 2021
Cystoscopy and Ureteroscopy Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type [Cystoscope (Rigid and Flexible), and Ureteroscope (Flexible and Semi-Flexible)], Procedure (Stone Management, Bladder Cancer, Benign Prostatic Hyperplasia, and Others), Technology (Fiberoptic and Video), Usage Type (Reusable and Single Use), End User (Hospitals, Ambulatory Surgical Centers and Specialty Clinics), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, South and Central America)
Sep 2021
Cancer Drugs Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Chemotherapy, Targeted Therapy, Radiation Therapy, Hormone Therapy, and Other Therapy Types), By Indications (Blood Cancer, Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, Cervical Cancer, Liver and Intrahepatic Bile Ducts Cancer, Thyroid Cancer, and Other Indications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Stores), and Geography
Sep 2021
Walking Aids Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Canes, Crutches, Walkers, Rollators, and Others), Age Group (Adults and Pediatric), Application (Neurologically Impaired, Handicap Patients, and Others), End User (Homecare, Hospitals and Clinics, Rehabilitation Centers, and Others), and Distribution Channel (Online and Offline)
Sep 2021
Infectious Disease In vitro Diagnostics Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Application (HIV or AIDS, Tuberculosis, Hepatitis B and C, Malaria, and Others), End User (Hospitals and Clinics, Diagnostic Laboratories, Blood Bank, and Others), and Geography
Sep 2021
Donor Blood Components Market
Size and Forecast (2021–2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Blood Component (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Indication (Immunosuppression and Oncology), Application (Anemia Management, Thrombocytopenia Treatment, Coagulopathy Correction, Supportive Care During Chemotherapy, Surgery, and Others), Age Group (Adult and Child), End User (Hospitals, Oncology Centers, Transplant Centers, Ambulatory Surgical Centers, and Others), and Geography
Sep 2021
Aesthetic Injectable Devices Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product (Dermal Filler, Botulinum Toxin and Others), Dermal Fillers (Calcium Hydroxylapatite, Hyaluronic Acid, Collagen, Poly-L-Lactic Acid, Polymethylmethacrylate, Fat Fillers, and Others), Device Type (Microcannulas, Pre-Filled Syringes, Mesotherapy Guns, and Others), Application (Facial Line Correction, Face Lift, Lip Treatment, Anti-Ageing and Wrinkle Treatment, Acne and Scar Treatment, Stretch Marks, and Others), Age Group (Up to 30, 31-40, 41-50, 51-60, and More Than 60), Gender (Female and Male), End User (Medical Spas, Dermatology Clinics, Hospitals, and Others), and Geography
Sep 2021
ECG Monitoring Equipment Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Resting ECG, Stress ECG, Holter Monitors, and Cardiopulmonary Stress Testing Monitors), Lead Type (12-Lead ECG, 3–6 Lead ECG, and Single Lead), Technology [Portable (Wired) ECG System and Wireless ECG System], End User (Hospital and Clinics, Ambulatory Surgical Centers, Cardiac Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Get Free Sample For